Andexanet alfa for reversal of rivaroxaban in a child with intracranial hemorrhage.

Authors :: Takasaki K
Hehir D
Raffini L
Samelson-Jones BJ
Shih E
Dain AS
Source :: Pediatric blood & cancer [Pediatr Blood Cancer] 2022 Jun; Vol. 69 (6), pp. e29484. Date of Electronic Publication: 2021 Nov 22.
Publication Year :: 2022

Subjects :: Anticoagulants
Child
Factor Xa Inhibitors adverse effects
Humans
Intracranial Hemorrhages chemically induced
Intracranial Hemorrhages drug therapy
Pyridones
Recombinant Proteins therapeutic use
Factor Xa
Rivaroxaban therapeutic use

Full Text Access

Tools